Q2 Holdings
QTWO
57.63
+0.21
+0.37%
Q2 Holdings
US · QTWO
#2358 by market cap
Listed 1970
57.63
+0.21
+0.37%
Live - 5344 symbols - heartbeat 145s ago
· 2026-10-08 07:58
Pre-market
57.63
0.00%
After-hours
57.63
0.00%
- Market cap
- 3.59B
- P/E (TTM)i
- 40.58
- P/Bi
- 5.58
- EPSi
- 0.80
- Div yieldi
- 0.00%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on QTWO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.58, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.12% YoY
Margins
- Gross margin
- 54.06%
- Operating margin
- 5.52%
- Net margin
- 6.54%
Key ratios & quality
- Altman Z-Scorei
- 3.58
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 241.10M | 315.48M | 402.75M | 498.72M | 565.67M | 624.62M | 696.46M | 794.81M |
| Gross profit | 119.25M | 153.00M | 174.60M | 225.04M | 256.35M | 302.65M | 354.48M | 429.68M |
| Selling & admin expenses | 93.77M | 121.11M | 145.44M | 163.48M | 198.38M | 219.71M | 228.89M | 231.37M |
| Research & development | 51.33M | 76.27M | 97.38M | 116.95M | 130.10M | 137.33M | 143.24M | 154.33M |
| Operating profit | -27.71M | -50.72M | -86.11M | -73.30M | -90.38M | -75.06M | -34.64M | 43.89M |
| Pretax profit | -39.20M | -83.36M | -136.20M | -111.10M | -106.08M | -61.82M | -30.86M | 54.73M |
| Tax | -3.80M | -12.49M | 1.42M | 1.64M | 2.91M | 3.56M | 7.68M | 2.72M |
| Net profit | -35.40M | -70.88M | -137.62M | -112.75M | -108.98M | -65.38M | -38.54M | 52.01M |
| Basic EPS | -1 | -2 | -3 | -2 | -2 | -1 | -1 | 1 |
| Diluted EPS | -0.83 | -1.53 | -2.65 | -2.00 | -1.90 | -1.12 | -0.64 | 0.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 189.74M | 195.15M | 201.70M | 208.22M | 216.51M | 219.77M |
| Gross profit | 100.99M | 104.56M | 108.85M | 115.28M | 127.91M | 130.20M |
| Selling & admin expenses | 58.85M | 58.07M | 58.11M | 56.35M | 57.91M | 59.01M |
| Research & development | 37.85M | 36.91M | 38.93M | 40.63M | 41.88M | 41.12M |
| Operating profit | 4.20M | 9.58M | 11.81M | 18.31M | 28.13M | 30.07M |
| Pretax profit | 5.24M | 13.50M | 15.21M | 20.78M | 29.75M | 31.72M |
| Tax | 487.00K | 1.73M | 160.00K | 337.00K | 3.11M | 1.86M |
| Net profit | 4.75M | 11.76M | 15.05M | 20.44M | 26.64M | 29.86M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.07 | 0.18 | 0.23 | 0.31 | 0.40 | 0.46 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 218.31M | 186.34M | 616.22M | 522.45M | 531.08M | 427.96M | 558.66M | 556.05M |
| Cash & ST investments | 177.32M | 132.42M | 539.06M | 427.73M | 433.35M | 324.01M | 446.63M | 432.70M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 463.72M | 1.01B | 1.42B | 1.39B | 1.35B | 1.20B | 1.29B | 1.28B |
| Total current liabilities | 73.68M | 132.97M | 145.83M | 168.36M | 192.04M | 191.56M | 398.90M | 544.09M |
| Short-term debt | -- | 9.14M | 6.84M | 9.00M | 22.56M | 12.86M | 202.53M | 312.99M |
| Long-term debt | 182.72M | 424.78M | 557.47M | 551.60M | 657.79M | 490.46M | 302.12M | -- |
| Total liabilities | 304,820,000.00 | 630,022,000.00 | 773,338,000.00 | 814,749,000.00 | 930,702,000.00 | 752,946,000.00 | 776,999,000.00 | 614,466,000.00 |
| Total equity | 158.90M | 379.41M | 643.36M | 570.30M | 419.02M | 448.48M | 517.80M | 661.81M |
| Retained earnings | -172.42M | -243.30M | -381.19M | -493.93M | -560.31M | -625.69M | -664.23M | -612.22M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 618.78M | 659.75M | 707.27M | 556.05M | 524.57M | 244.47M |
| Cash & ST investments | 486.05M | 532.07M | 568.73M | 432.70M | 378.89M | 106.43M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.35B | 1.39B | 1.43B | 1.28B | 1.25B | 968.42M |
| Total current liabilities | 432.16M | 732.28M | 731.65M | 544.09M | 562.49M | 258.81M |
| Short-term debt | 200.60M | 502.80M | 503.02M | 312.99M | 312.31M | 8.69M |
| Long-term debt | 302.43M | -- | -- | -- | -- | -- |
| Total liabilities | 804,398,000.00 | 801,078,000.00 | 803,816,000.00 | 614,466,000.00 | 634,671,000.00 | 324,964,000.00 |
| Total equity | 545.46M | 584.34M | 622.89M | 661.81M | 611.68M | 643.45M |
| Retained earnings | -659.48M | -647.71M | -632.67M | -612.22M | -585.58M | -555.73M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.60M | 567.00K | -2.89M | 31.09M | 36.56M | 70.29M | 135.75M | 201.46M |
| Depreciation & amortization | 16.80M | 28.46M | 51.84M | 54.83M | 61.66M | 71.71M | 68.81M | 53.42M |
| Free cash flow | -8.74M | -13.76M | -27.56M | 5.47M | 6.50M | 39.65M | 106.72M | 173.37M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 195.29M | 311.32M | -- | -- | 0 | 0 | -5.00M |
| Ending cash balance | 110.16M | 103.56M | 411.19M | 325.82M | 201.90M | 233.63M | 360.79M | 369.30M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 43.53M | 48.64M | 45.59M | 63.70M | 56.32M | 60.65M |
| Depreciation & amortization | 13.72M | 13.56M | 13.61M | 12.54M | 11.74M | 12.06M |
| Free cash flow | 37.83M | 41.70M | 37.25M | 56.59M | 44.21M | 50.99M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | -97.15M | -22.93M |
| Ending cash balance | 385.48M | 416.02M | 474.53M | 369.30M | 344.39M | 102.14M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -26.66 | -26.33 | -26.91 | -18.58 | -22.03 | -15.07 | -7.98 | 8.82 |
| ROA %i | -10.46 | -9.62 | -11.34 | -8.05 | -7.97 | -5.13 | -3.09 | 4.05 |
| ROIC %i | -9.12 | -9.46 | -11.23 | -7.36 | -9.22 | -6.41 | -4.62 | 3.66 |
| 5-year avg ROE %i | -40.75 | -27.41 | -27.70 | -24.76 | -24.10 | -21.79 | -18.11 | -10.97 |
| EBIT margin %i | -12.04 | -19.99 | -26.71 | -15.65 | -17.57 | -8.98 | -3.72 | 7.57 |
| FCF / sales %i | -- | -- | -- | 1.06 | 1.15 | 6.35 | 15.32 | 21.81 |
| Current ratioi | 2.96 | 1.40 | 4.23 | 3.10 | 2.77 | 2.23 | 1.40 | 1.02 |
| Quick ratioi | 2.68 | 1.17 | 3.95 | 2.83 | 2.55 | 1.96 | 1.24 | 0.91 |
| Debt / assetsi | 39.40 | 46.56 | 42.43 | 44.91 | 54.33 | 45.69 | 41.94 | 27.17 |
| LT debt / equityi | 114.99 | 121.47 | 92.36 | 107.48 | 169.63 | 119.53 | 65.75 | 5.11 |
| Interest coveragei | -2.86 | -3.11 | -3.75 | -2.36 | -14.89 | -9.79 | -5.25 | 11.12 |
| Revenue CAGR (3Y) %i | 30.35 | 28.06 | 27.57 | 27.41 | 21.49 | 15.75 | 11.78 | 12.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | 169.16 | 198.72 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -3.95 | 0.92 | 5.68 | 8.82 | 12.77 | 14.98 |
| ROA %i | -1.55 | 0.37 | 2.35 | 4.05 | 5.69 | 7.82 |
| ROIC %i | -2.85 | -0.54 | 1.73 | 3.66 | 5.98 | 8.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -1.13 | 2.23 | 5.36 | 7.57 | 10.26 | 12.08 |
| FCF / sales %i | 19.22 | 20.39 | 19.96 | 21.81 | 21.88 | 22.34 |
| Current ratioi | 1.43 | 0.90 | 0.97 | 1.02 | 0.93 | 0.94 |
| Quick ratioi | 1.28 | 0.82 | 0.88 | 0.91 | 0.82 | 0.72 |
| Debt / assetsi | 39.93 | 38.93 | 37.79 | 27.17 | 27.59 | 4.23 |
| LT debt / equityi | 62.05 | 6.25 | 5.79 | 5.11 | 5.16 | 5.01 |
| Interest coveragei | -1.57 | 3.06 | 7.72 | 11.12 | 16.60 | 21.47 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Sale, implementation and support of the Company's solutions100.00%
Quote time 2026-10-08 07:58:18 · For reference only, not investment advice and not tailored to your situation.